ULTRASE MT 20
Generic Name: pancrelipase
Pill imprint ULTRASE MT 20 has been identified as Ultrase MT 20 65,000 units amylase; 20,000 units lipase; 65,000 units protease.
Ultrase MT 20 is used in the treatment of chronic pancreatitis; pancreatic exocrine dysfunction; cystic fibrosis and belongs to the drug class digestive enzymes. Risk cannot be ruled out during pregnancy.
Ultrase MT 20 65,000 units amylase; 20,000 units lipase; 65,000 units protease is not subject to the Controlled Substances Act.
See also related documents.
Ultrase MT 20 Images
- Generic Name:
- pancrelipase
- Imprint:
-
ULTRASE
MT 20 - Strength:
- 65,000 units amylase; 20,000 units lipase; 65,000 units protease
- Color:
- Gray / Yellow
- Shape:
- Capsule-shape
- Availability:
- Rx and/or OTC
- Drug Class:
- Digestive enzymes
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Axcan Scandipharm Inc.
- National Drug Code (NDC):
- 58914-0004
More Ultrase MT 20 resources
- Ultrase MT 20 (Cerner Multum)


